Vascular News and Research

RSS

Patch angioplasty improves post-exercise ABI's and reduces reoperation rates in competitive cyclists

Results from a midterm study of highly competitive cyclists who underwent external iliac artery reconstruction (AR) and inguinal ligament release (LR) were reported today at the 65th Vascular Annual Meeting® presented by the Society for Vascular Surgery (SVS).

21 May 2011

Cordis EXOSEAL Vascular Closure Device receives approval in the U.S.

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL Vascular Closure Device in the US. EXOSEAL incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure.

21 May 2011

Meta-analysis confirms positive outcomes in patients implanted with Medtronic CoreValve System

A late-breaking presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 today confirmed positive outcomes in patients receiving the CoreValve System from Medtronic, Inc. across seven international clinical registries.

From Medtronic 20 May 2011

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.

20 May 2011

Positive six-month results from BIOSOLVE-I FIM trial of DRug-Eluting Absorbable Metal Scaffold device

Six-month results from the BIOSOLVE-I first-in-man (FIM) trial, studying the DRug-Eluting Absorbable Metal Scaffold (DREAMS), demonstrate a high safety profile of the novel device.

19 May 2011

Medtronic issues statement on results of CoreValve System clinical data presented at EuroPCR 2011

Medtronic, Inc. today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve System, delivered through a new approach beneath the collarbone, achieved excellent procedural success rates and low in-hospital complication rates.

From Medtronic 19 May 2011

Aspirin, simvastatin not effective in combating pulmonary artery hypertension

Despite their beneficial effects in treating heart disease, neither aspirin nor simvastatin appear to offer benefit to patients suffering from pulmonary artery hypertension (PAH), according to a National Institutes of Health (NIH)-funded study conducted at four U.S. medical centers. This was the first NIH-funded randomized clinical trial (RCT) in PAH.

19 May 2011

New gripping and safety device to protect nurses' fingers and hands to be displayed at INS meeting

MedeGrip™, a new gripping and safety device that protects nurses' fingers and hands, will be displayed next week at the Infusion Nurses Society (INS) annual meeting. The device makes it easier and safer for nurses to perform various essential duties.

18 May 2011

Improved tissue grafts promote vascular growth in wound sites

Victims of third-degree burns and other traumatic injuries endure pain, disfigurement, invasive surgeries and a long time waiting for skin to grow back. Improved tissue grafts designed by Cornell scientists that promote vascular growth could hasten healing, encourage healthy skin to invade the wounded area and reduce the need for surgeries.

18 May 2011

Clinical data of Medtronic's Resolute drug-eluting stent in diabetes presented at EuroPCR meeting

For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent from Medtronic, Inc., provided remarkably safe and effective outcomes, according to the results of several studies presented today at EuroPCR, a major international meeting for cardiac and vascular specialists.

From Medtronic 18 May 2011

Queen's University scientists partner to treat premature baby blindness with stem cells

Scientists from the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast are teaming up to develop a cure to an illness that can lead to blindness in premature babies, thanks to funding from children's charity Action Medical Research.

18 May 2011

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. today announced recent milestones in its clinical program for the IN.PACT drug-eluting balloon technology.

From Medtronic 17 May 2011

Histogenics announces acquisition of ProChon Biotech

Histogenics Corporation, a privately held regenerative medicine company, announced today that it has acquired ProChon Biotech, Ltd. in a stock-for-stock exchange.

17 May 2011

Volcano to share intravascular therapy guidance and optimization solutions at EuroPCR

Volcano Corporation today announced its participation in the Paris course for Revascularization from May 17 – 20. Volcano's focus will be on highlighting the strength of its product portfolio, which includes innovative devices like the Vascular Imaging Balloon Catheter, and its sponsorship of a symposium that highlights the use and value of Precision Guided Therapy in clinical practice today.

16 May 2011

First fetoscopic laser procedure to correct Twin-Twin Transfusion syndrome performed in Dallas

Jessica and Chad Browning were ecstatic last fall when they learned they were expecting twins. They had two children already, but wanted a third to round out their family. Twins were a bonus.

16 May 2011

Gene manipulation can improve survival rates during sepsis infection

Sepsis is a major killer in hospital intensive care units. Researchers at Case Western Reserve University School of Medicine have found that manipulating a genetic factor that can launch or throttle the body's defenses can improve survival rates during bacterial infection.

13 May 2011

59-year-old enrolls in study of stem cell transplantation during cardiac bypass

A 59-year-old Houston man became the first individual in the United States to enroll in a study using stem cell transplantation during cardiac bypass to treat severe heart failure.

12 May 2011

Medtronic to present new clinical results on innovative medical devices at EuroPCR

New clinical data on a range of innovative medical devices from Medtronic, Inc., to treat cardiac and vascular diseases - from severe aortic stenosis and uncontrolled hypertension, to coronary and peripheral artery disease - will be presented next week at EuroPCR. Many of the presentations will be featured during late-breaking sessions at this large international interventional cardiology meeting, which takes place in Paris from May 17-20.

From Medtronic 12 May 2011

China Pharma first quarter revenue increases 20% to $18.1 million

China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the quarter ended March 31, 2011.

11 May 2011

'Healthy' smokers have gene expression profiles similar to COPD patients

'Healthy' smokers experience changes in the gene expression of their lungs similar to that suffered by smokers who have developed Chronic Obstructive Pulmonary Disease (COPD). This is the conclusion of a new study, led by Catalan researchers, which confirms the crucial role that smoking plays in causing these alterations.

10 May 2011

Vascular News and Research

Patch angioplasty improves post-exercise ABI's and reduces reoperation rates in competitive cyclists

Cordis EXOSEAL Vascular Closure Device receives approval in the U.S.

Meta-analysis confirms positive outcomes in patients implanted with Medtronic CoreValve System

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

Positive six-month results from BIOSOLVE-I FIM trial of DRug-Eluting Absorbable Metal Scaffold device

Medtronic issues statement on results of CoreValve System clinical data presented at EuroPCR 2011

Aspirin, simvastatin not effective in combating pulmonary artery hypertension

New gripping and safety device to protect nurses' fingers and hands to be displayed at INS meeting

Improved tissue grafts promote vascular growth in wound sites

Clinical data of Medtronic's Resolute drug-eluting stent in diabetes presented at EuroPCR meeting

Queen's University scientists partner to treat premature baby blindness with stem cells

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

Histogenics announces acquisition of ProChon Biotech

Volcano to share intravascular therapy guidance and optimization solutions at EuroPCR

First fetoscopic laser procedure to correct Twin-Twin Transfusion syndrome performed in Dallas

Gene manipulation can improve survival rates during sepsis infection

59-year-old enrolls in study of stem cell transplantation during cardiac bypass

Medtronic to present new clinical results on innovative medical devices at EuroPCR

China Pharma first quarter revenue increases 20% to $18.1 million

'Healthy' smokers have gene expression profiles similar to COPD patients

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News